[Form 4] Avantor, Inc. Insider Trading Activity
Avantor, Inc. (AVTR) 鈥� SEC Form 4 filing
Company insider Corey Walker, President of Laboratory Solutions, reported a routine tax-related share withholding on 21 June 2025. The filing shows 2,730 common shares (transaction code F) were surrendered at an indicated price of $13.57 to satisfy statutory withholding obligations triggered by the vesting of restricted stock units (RSUs). After the transaction, Walker continues to hold 231,271 shares directly.
No derivative security activity, 10b5-1 plan disclosure, or additional insider transactions were reported. The small size of the disposition (鈮�1.2 % of Walker鈥檚 post-transaction holdings) and its tax-withholding nature make the event immaterial to the company鈥檚 capital structure and unlikely to influence the investment thesis for AVTR.
Avantor, Inc. (AVTR) 鈥� Comunicazione SEC Modulo 4
L鈥檌nsider aziendale Corey Walker, Presidente delle Soluzioni di Laboratorio, ha segnalato un ritenuta fiscale ordinaria sulle azioni in data 21 giugno 2025. La comunicazione indica che sono state cedute 2.730 azioni ordinarie (codice transazione F) ad un prezzo indicato di 13,57 $ per adempiere agli obblighi di ritenuta fiscale derivanti dalla maturazione di unit脿 azionarie vincolate (RSU). Dopo la transazione, Walker detiene direttamente 231.271 azioni.
Non sono state segnalate attivit脿 su strumenti derivati, piani 10b5-1 o altre transazioni da insider. La modesta entit脿 della cessione (circa l鈥�1,2% delle azioni detenute da Walker dopo la transazione) e la sua natura fiscale rendono l鈥檈vento irrilevante per la struttura patrimoniale della societ脿 e poco probabile che influenzi la strategia d鈥檌nvestimento in AVTR.
Avantor, Inc. (AVTR) 鈥� Presentaci贸n SEC Formulario 4
El insider de la compa帽铆a Corey Walker, Presidente de Soluciones de Laboratorio, inform贸 una retenci贸n de acciones rutinaria relacionada con impuestos el 21 de junio de 2025. La presentaci贸n muestra que se entregaron 2,730 acciones ordinarias (c贸digo de transacci贸n F) a un precio indicado de $13.57 para cumplir con las obligaciones legales de retenci贸n derivadas de la consolidaci贸n de unidades de acciones restringidas (RSU). Despu茅s de la transacci贸n, Walker sigue poseyendo 231,271 acciones directamente.
No se reportaron actividades con valores derivados, divulgaci贸n de planes 10b5-1 ni otras transacciones de insiders. El peque帽o volumen de la disposici贸n (鈮�1.2 % de las tenencias posteriores a la transacci贸n de Walker) y su naturaleza de retenci贸n fiscal hacen que el evento sea insignificante para la estructura de capital de la empresa y poco probable que influya en la tesis de inversi贸n para AVTR.
Avantor, Inc. (AVTR) 鈥� SEC 鞏戩嫕 4 鞝滌稖
須岇偓 雮措秬鞛� 旖旊Μ 鞗岇护(Corey Walker) 鞁ろ棙鞁� 靻旊（靺� 攵�靷灔鞚� 2025雲� 6鞗� 21鞚�鞐� 鞚检儊鞝侅澑 靹戈笀 甏�霠� 欤检嫕 鞗愳矞歆曥垬毳� 氤搓碃頄堨姷雼堧嫟. 鞝滌稖靹滊鞐� 霐半ゴ氅� 2,730欤� 氤错喌欤�(瓯半灅 旖旊摐 F)臧� 鞝滍暅 欤检嫕 雼渼(RSU)鞚� 甓岆Μ 頇曥爼鞐� 霐半ジ 氩曥爼 鞗愳矞歆曥垬 鞚橂毳� 於╈”頃橁赴 鞙勴暣 欤茧嫻 $13.57鞚� 臧�瓴╈溂搿� 觳橂秳霅橃棃鞀惦媹雼�. 瓯半灅 頉� 鞗岇护電� 鞐爠頌� 231,271欤�毳� 歆侅爲 氤挫湢頃橁碃 鞛堨姷雼堧嫟.
韺岇儩靸來拡 頇滊彊, 10b5-1 瓿勴殟 瓿店皽 霕愲姅 於旉皜 雮措秬鞛� 瓯半灅電� 氤搓碃霅橃 鞎婌晿鞀惦媹雼�. 觳橂秳 攴滊臧� 鞛戧碃(瓯半灅 頉� 鞗岇护 氤挫湢 欤检嫕鞚� 鞎� 1.2%) 靹戈笀 鞗愳矞歆曥垬 靹标博鞚措瘈搿� 鞚� 靷贝鞚� 須岇偓 鞛愲掣 甑“鞐� 欷戩殧頃橃 鞎婌溂氅� AVTR 韴瀽 雲茧Μ鞐� 鞓來枼鞚� 氙胳範 臧�電レ劚霃� 雮姷雼堧嫟.
Avantor, Inc. (AVTR) 鈥� D茅p么t SEC Formulaire 4
Le dirigeant interne Corey Walker, Pr茅sident des Solutions de Laboratoire, a d茅clar茅 une retenue d鈥檃ctions li茅e aux imp么ts de routine le 21 juin 2025. Le d茅p么t indique que 2 730 actions ordinaires (code de transaction F) ont 茅t茅 c茅d茅es 脿 un prix indiqu茅 de 13,57 $ afin de satisfaire aux obligations l茅gales de retenue 脿 la source d茅clench茅es par l鈥檃cquisition d鈥檜nit茅s d鈥檃ctions restreintes (RSU). Apr猫s la transaction, Walker d茅tient directement 231 271 actions.
Aucune activit茅 sur titres d茅riv茅s, divulgation d鈥檜n plan 10b5-1 ou transactions suppl茅mentaires d鈥檌niti茅s n鈥檕nt 茅t茅 rapport茅es. La faible taille de la cession (鈮�1,2 % des avoirs post-transaction de Walker) et sa nature fiscale rendent l鈥櫭﹙茅nement peu significatif pour la structure du capital de la soci茅t茅 et peu susceptible d鈥檌nfluencer la th猫se d鈥檌nvestissement pour AVTR.
Avantor, Inc. (AVTR) 鈥� SEC Formular 4 Einreichung
Firmeninsider Corey Walker, Pr盲sident der Laboratory Solutions, meldete am 21. Juni 2025 eine routinebedingte steuerliche Aktieneinbehaltung. Die Einreichung zeigt, dass 2.730 Stammaktien (Transaktionscode F) zu einem angegebenen Preis von 13,57 $ abgegeben wurden, um gesetzliche Einbehaltspflichten aufgrund der Vesting von Restricted Stock Units (RSUs) zu erf眉llen. Nach der Transaktion h盲lt Walker weiterhin 231.271 Aktien direkt.
Keine Aktivit盲ten mit derivativen Wertpapieren, keine 10b5-1-Plan-Offenlegung oder zus盲tzliche Insidertransaktionen wurden gemeldet. Die geringe Gr枚脽e der Ver盲u脽erung (鈮�1,2 % von Walkers Best盲nden nach der Transaktion) und deren steuerliche Natur machen das Ereignis unwichtig f眉r die Kapitalstruktur des Unternehmens und es ist unwahrscheinlich, dass es die Investmentthese f眉r AVTR beeinflusst.
- None.
- None.
Insights
TL;DR: Routine tax withholding; negligible impact on AVTR valuation.
The Form 4 shows an officer surrendering 2,730 shares鈥攋ust over 1 % of his stake鈥攖o cover RSU taxes. No open-market sale, so there鈥檚 no bearish signal on fundamentals. With 231k shares still owned, alignment of management and shareholder interests remains intact. The transaction size is immaterial relative to Avantor鈥檚 675 million outstanding shares; therefore, it should not affect liquidity, float, or sentiment.
TL;DR: Governance-neutral filing; complies with Section 16 reporting.
The insider met Section 16 obligations, filing within two business days. Code F confirms shares were withheld by the issuer, aligning with standard corporate practices for RSU tax settlement. No 10b5-1 box was marked, suggesting the withholding was automatic, not discretionary. There are no red flags regarding compliance or insider confidence.
Avantor, Inc. (AVTR) 鈥� Comunicazione SEC Modulo 4
L鈥檌nsider aziendale Corey Walker, Presidente delle Soluzioni di Laboratorio, ha segnalato un ritenuta fiscale ordinaria sulle azioni in data 21 giugno 2025. La comunicazione indica che sono state cedute 2.730 azioni ordinarie (codice transazione F) ad un prezzo indicato di 13,57 $ per adempiere agli obblighi di ritenuta fiscale derivanti dalla maturazione di unit脿 azionarie vincolate (RSU). Dopo la transazione, Walker detiene direttamente 231.271 azioni.
Non sono state segnalate attivit脿 su strumenti derivati, piani 10b5-1 o altre transazioni da insider. La modesta entit脿 della cessione (circa l鈥�1,2% delle azioni detenute da Walker dopo la transazione) e la sua natura fiscale rendono l鈥檈vento irrilevante per la struttura patrimoniale della societ脿 e poco probabile che influenzi la strategia d鈥檌nvestimento in AVTR.
Avantor, Inc. (AVTR) 鈥� Presentaci贸n SEC Formulario 4
El insider de la compa帽铆a Corey Walker, Presidente de Soluciones de Laboratorio, inform贸 una retenci贸n de acciones rutinaria relacionada con impuestos el 21 de junio de 2025. La presentaci贸n muestra que se entregaron 2,730 acciones ordinarias (c贸digo de transacci贸n F) a un precio indicado de $13.57 para cumplir con las obligaciones legales de retenci贸n derivadas de la consolidaci贸n de unidades de acciones restringidas (RSU). Despu茅s de la transacci贸n, Walker sigue poseyendo 231,271 acciones directamente.
No se reportaron actividades con valores derivados, divulgaci贸n de planes 10b5-1 ni otras transacciones de insiders. El peque帽o volumen de la disposici贸n (鈮�1.2 % de las tenencias posteriores a la transacci贸n de Walker) y su naturaleza de retenci贸n fiscal hacen que el evento sea insignificante para la estructura de capital de la empresa y poco probable que influya en la tesis de inversi贸n para AVTR.
Avantor, Inc. (AVTR) 鈥� SEC 鞏戩嫕 4 鞝滌稖
須岇偓 雮措秬鞛� 旖旊Μ 鞗岇护(Corey Walker) 鞁ろ棙鞁� 靻旊（靺� 攵�靷灔鞚� 2025雲� 6鞗� 21鞚�鞐� 鞚检儊鞝侅澑 靹戈笀 甏�霠� 欤检嫕 鞗愳矞歆曥垬毳� 氤搓碃頄堨姷雼堧嫟. 鞝滌稖靹滊鞐� 霐半ゴ氅� 2,730欤� 氤错喌欤�(瓯半灅 旖旊摐 F)臧� 鞝滍暅 欤检嫕 雼渼(RSU)鞚� 甓岆Μ 頇曥爼鞐� 霐半ジ 氩曥爼 鞗愳矞歆曥垬 鞚橂毳� 於╈”頃橁赴 鞙勴暣 欤茧嫻 $13.57鞚� 臧�瓴╈溂搿� 觳橂秳霅橃棃鞀惦媹雼�. 瓯半灅 頉� 鞗岇护電� 鞐爠頌� 231,271欤�毳� 歆侅爲 氤挫湢頃橁碃 鞛堨姷雼堧嫟.
韺岇儩靸來拡 頇滊彊, 10b5-1 瓿勴殟 瓿店皽 霕愲姅 於旉皜 雮措秬鞛� 瓯半灅電� 氤搓碃霅橃 鞎婌晿鞀惦媹雼�. 觳橂秳 攴滊臧� 鞛戧碃(瓯半灅 頉� 鞗岇护 氤挫湢 欤检嫕鞚� 鞎� 1.2%) 靹戈笀 鞗愳矞歆曥垬 靹标博鞚措瘈搿� 鞚� 靷贝鞚� 須岇偓 鞛愲掣 甑“鞐� 欷戩殧頃橃 鞎婌溂氅� AVTR 韴瀽 雲茧Μ鞐� 鞓來枼鞚� 氙胳範 臧�電レ劚霃� 雮姷雼堧嫟.
Avantor, Inc. (AVTR) 鈥� D茅p么t SEC Formulaire 4
Le dirigeant interne Corey Walker, Pr茅sident des Solutions de Laboratoire, a d茅clar茅 une retenue d鈥檃ctions li茅e aux imp么ts de routine le 21 juin 2025. Le d茅p么t indique que 2 730 actions ordinaires (code de transaction F) ont 茅t茅 c茅d茅es 脿 un prix indiqu茅 de 13,57 $ afin de satisfaire aux obligations l茅gales de retenue 脿 la source d茅clench茅es par l鈥檃cquisition d鈥檜nit茅s d鈥檃ctions restreintes (RSU). Apr猫s la transaction, Walker d茅tient directement 231 271 actions.
Aucune activit茅 sur titres d茅riv茅s, divulgation d鈥檜n plan 10b5-1 ou transactions suppl茅mentaires d鈥檌niti茅s n鈥檕nt 茅t茅 rapport茅es. La faible taille de la cession (鈮�1,2 % des avoirs post-transaction de Walker) et sa nature fiscale rendent l鈥櫭﹙茅nement peu significatif pour la structure du capital de la soci茅t茅 et peu susceptible d鈥檌nfluencer la th猫se d鈥檌nvestissement pour AVTR.
Avantor, Inc. (AVTR) 鈥� SEC Formular 4 Einreichung
Firmeninsider Corey Walker, Pr盲sident der Laboratory Solutions, meldete am 21. Juni 2025 eine routinebedingte steuerliche Aktieneinbehaltung. Die Einreichung zeigt, dass 2.730 Stammaktien (Transaktionscode F) zu einem angegebenen Preis von 13,57 $ abgegeben wurden, um gesetzliche Einbehaltspflichten aufgrund der Vesting von Restricted Stock Units (RSUs) zu erf眉llen. Nach der Transaktion h盲lt Walker weiterhin 231.271 Aktien direkt.
Keine Aktivit盲ten mit derivativen Wertpapieren, keine 10b5-1-Plan-Offenlegung oder zus盲tzliche Insidertransaktionen wurden gemeldet. Die geringe Gr枚脽e der Ver盲u脽erung (鈮�1,2 % von Walkers Best盲nden nach der Transaktion) und deren steuerliche Natur machen das Ereignis unwichtig f眉r die Kapitalstruktur des Unternehmens und es ist unwahrscheinlich, dass es die Investmentthese f眉r AVTR beeinflusst.
FAQ
How many Avantor (AVTR) shares did Corey Walker dispose of in this Form 4?
What was the purpose of the AVTR share disposition?
What price was assigned to the withheld shares?
How many AVTR shares does Corey Walker own after the transaction?
Did the filing indicate the use of a Rule 10b5-1 trading plan?
